This is an old revision of this page, as edited by Beetstra (talk | contribs) at 20:41, 10 November 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:41, 10 November 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
Trade names | Suprax |
AHFS/Drugs.com | Monograph |
MedlinePlus | a690007 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 40% to 50% |
Protein binding | Approximately 60% |
Elimination half-life | Variable Average 3 to 4 hours |
Excretion | Renal and biliary |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.119.331 |
Chemical and physical data | |
Formula | C16H15N5O7S2 |
Molar mass | 453.452 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Cefixime is an oral third generation cephalosporin antibiotic. Cefixime is a cephalosporin antibiotic used to treat infections caused by bacteria such as pneumonia; bronchitis; gonorrhea; and ear, lung, throat, and urinary tract infections. Antibiotics will not work for colds, flu, or other viral infections.
It was sold under the trade name Suprax in the USA until 2003 when it was taken off the market by drug manufacturer Wyeth after its patent expired. The oral suspension form of "Suprax" was re-launched by Lupin in the USA.
Cefixime API is manufactured by many pharmaceutical companies the world over. The major manufacturers are based in India.
References
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a690007.html
Categories: